What Researchers Did
Researchers conducted a detailed narrative review of publications to summarize the clinical efficacy of established and novel therapeutic modalities for managing mandibular osteoradionecrosis (MORN).
What They Found
They found a paradigm shift away from hyperbaric oxygen therapy, with growing evidence supporting pentoxifylline and tocopherol for early-stage disease and novel surgical techniques for moderate and late-stage MORN. The review proposes an updated staging stratification and a contemporary treatment algorithm integrating these advancements.
What This Means for Canadian Patients
Canadian patients with mandibular osteoradionecrosis may benefit from updated treatment approaches that move away from hyperbaric oxygen therapy. These new strategies emphasize early intervention with medications like pentoxifylline and tocopherol, alongside advanced surgical techniques for later stages.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
As a narrative review, this study's findings are based on a synthesis of existing literature without a systematic review methodology, which may introduce selection bias.